BR112016009757A8 - “inibidores do vírus sincicial respiratório com base em quinazolina” - Google Patents
“inibidores do vírus sincicial respiratório com base em quinazolina”Info
- Publication number
- BR112016009757A8 BR112016009757A8 BR112016009757A BR112016009757A BR112016009757A8 BR 112016009757 A8 BR112016009757 A8 BR 112016009757A8 BR 112016009757 A BR112016009757 A BR 112016009757A BR 112016009757 A BR112016009757 A BR 112016009757A BR 112016009757 A8 BR112016009757 A8 BR 112016009757A8
- Authority
- BR
- Brazil
- Prior art keywords
- quinazoline
- respiratory syncytial
- syncytial virus
- virus inhibitors
- based respiratory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
os compostos da fórmula (i), em que r1, r2, r3, r4 e n são definidos neste relatório, são úteis como inibidores de vsr.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2013/067276 WO2015065338A1 (en) | 2013-10-29 | 2013-10-29 | Quinazoline based respiratory syncytial virus inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112016009757A8 true BR112016009757A8 (pt) | 2018-01-30 |
Family
ID=53004759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016009757A BR112016009757A8 (pt) | 2013-10-29 | 2013-10-29 | “inibidores do vírus sincicial respiratório com base em quinazolina” |
Country Status (11)
Country | Link |
---|---|
US (1) | US9708332B2 (pt) |
EP (1) | EP3063149A1 (pt) |
JP (1) | JP2016535043A (pt) |
KR (1) | KR20160075766A (pt) |
CN (1) | CN105683190A (pt) |
AU (1) | AU2013404035B2 (pt) |
BR (1) | BR112016009757A8 (pt) |
CA (1) | CA2926369A1 (pt) |
HK (1) | HK1219482A1 (pt) |
RU (1) | RU2016120763A (pt) |
WO (1) | WO2015065338A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6739516B2 (ja) * | 2015-07-30 | 2020-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸器合胞体ウイルス阻害剤 |
WO2018038667A1 (en) * | 2016-08-25 | 2018-03-01 | Medivir Ab | Respiratory syncytial virus inhibitors |
WO2018038668A1 (en) * | 2016-08-25 | 2018-03-01 | Medivir Ab | Respiratory syncytial virus inhibitors |
US11713319B2 (en) | 2016-11-30 | 2023-08-01 | Merck Patent Gmbh | Compounds having valerolactam structures |
US11192893B2 (en) * | 2017-05-18 | 2021-12-07 | The Rockefeller University | Pyrazoloquinazolinone antitumor agents |
CA3138938A1 (en) | 2019-05-30 | 2020-12-03 | Aligos Therapeutics, Inc. | Tricyclic compounds |
US20230118497A1 (en) * | 2019-12-10 | 2023-04-20 | Shanghai Hansoh Biomedical Co., Ltd. | Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereof |
CN111499644B (zh) * | 2020-04-24 | 2021-07-20 | 苏州大学 | 咪唑并[1,5-a]喹唑啉-5(4H)-酮类衍生物及其制备方法和用途 |
CA3201456A1 (en) | 2020-11-24 | 2022-06-02 | Aligos Therapeutics, Inc. | Tricyclic compounds |
MX2023008677A (es) | 2021-01-27 | 2023-10-03 | Vandria Sa | Derivados de urolitinas y métodos para su uso. |
AU2022290123A1 (en) * | 2021-06-09 | 2023-12-14 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Salt and crystal form of pyrazole-containing polycyclic derivative, and preparation method therefor and use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489338B2 (en) | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
US6506738B1 (en) * | 2000-09-27 | 2003-01-14 | Bristol-Myers Squibb Company | Benzimidazolone antiviral agents |
US6774134B2 (en) | 2000-12-20 | 2004-08-10 | Bristol-Myers Squibb Company | Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
US7262200B2 (en) * | 2002-10-25 | 2007-08-28 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
WO2012078448A1 (en) * | 2010-12-06 | 2012-06-14 | Schering Corporation | Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors |
TWI541241B (zh) | 2010-12-16 | 2016-07-11 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類 |
-
2013
- 2013-10-29 AU AU2013404035A patent/AU2013404035B2/en not_active Ceased
- 2013-10-29 RU RU2016120763A patent/RU2016120763A/ru not_active Application Discontinuation
- 2013-10-29 EP EP13786872.5A patent/EP3063149A1/en not_active Withdrawn
- 2013-10-29 KR KR1020167014320A patent/KR20160075766A/ko not_active Application Discontinuation
- 2013-10-29 WO PCT/US2013/067276 patent/WO2015065338A1/en active Application Filing
- 2013-10-29 JP JP2016527217A patent/JP2016535043A/ja active Pending
- 2013-10-29 BR BR112016009757A patent/BR112016009757A8/pt not_active IP Right Cessation
- 2013-10-29 US US15/032,855 patent/US9708332B2/en not_active Expired - Fee Related
- 2013-10-29 CA CA2926369A patent/CA2926369A1/en not_active Abandoned
- 2013-10-29 CN CN201380080493.8A patent/CN105683190A/zh active Pending
-
2016
- 2016-06-28 HK HK16107533.1A patent/HK1219482A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20160075766A (ko) | 2016-06-29 |
CA2926369A1 (en) | 2015-05-07 |
HK1219482A1 (zh) | 2017-04-07 |
RU2016120763A (ru) | 2017-12-05 |
WO2015065338A1 (en) | 2015-05-07 |
EP3063149A1 (en) | 2016-09-07 |
JP2016535043A (ja) | 2016-11-10 |
US20160272646A1 (en) | 2016-09-22 |
CN105683190A (zh) | 2016-06-15 |
AU2013404035A1 (en) | 2016-04-28 |
AU2013404035B2 (en) | 2017-04-20 |
US9708332B2 (en) | 2017-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016009757A8 (pt) | “inibidores do vírus sincicial respiratório com base em quinazolina” | |
DOP2017000078A (es) | Indazoles sustituidos con bencilo como inhibidores de bub1. | |
DOP2017000267A (es) | Amidas heterocíclicas como inhibidores de quinasa | |
CR20180072A (es) | Nuevos compuestos biciclicos como inhibidores de atx | |
CR20180057A (es) | Nuevos compuestos biciclicos como inhibidores duales de atx/ca. | |
NI201400150A (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
BR112015028152A2 (pt) | inibidores de acc e usos dos mesmos | |
BR112015028171A8 (pt) | Inibidores de acc e seu uso | |
BR112018003343A2 (pt) | compostos heteroarila como inibidores de irak e usos dos mesmos | |
BR112016006319A2 (pt) | inibidores de irak e usos dos mesmos | |
BR112015028173A2 (pt) | inibidores de acc e usos dos mesmos | |
BR112018003812A2 (pt) | compostos de heteroarila como inibidores de irak e usos dos mesmos | |
EA201690473A1 (ru) | Комбинированный состав двух противовирусных соединений | |
UY34632A (es) | Compuestos de oxazolidin- 2- ona y usos de los mismos | |
BR112016029612A2 (pt) | compostos de di-hidroisoquinolinona substituídos | |
UY35661A (es) | Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que lo s contienen | |
CR20150470A (es) | Derivados de triazolona de piridinilo y piridinilo fusionado | |
UY34824A (es) | Nucleósidos de espirooxetano de uracilo | |
BR112014003693A2 (pt) | amino quinazolinas como inibidores de quinase | |
BR112017014970A2 (pt) | macrociclos de piridazinona como inibidores de irak e usos dos mesmos | |
CL2017002856A1 (es) | Compuestos de tioéter como inhibidores de la nitrificación | |
BR112016002638A2 (pt) | novos aza-oxo-indóis para o tratamento e profilaxia de infecção pelo virus sincicial respiratório | |
BR112015029462A8 (pt) | Inibidores de quinase | |
BR112017028549A2 (pt) | derivados de pirimidina como inibidores de btk e usos dos mesmos | |
EA201790939A1 (ru) | ТРИАЗОЛО[4,5-d]ПИРИМИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ КАННАБИНОИДНЫХ РЕЦЕПТОРОВ ТИПА 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2485 DE 21-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |